Imagine walking into a lab.
Rolling up your sleeve.
Giving a tiny blood sample…
…and walking out with the beginnings of a human egg.
Sounds like science fiction.
It just happened in California.
A biotech startup called Conception just announced something wild.
They've created the world's first early-stage human egg cells — from stem cells.
Not harvested. Not donated.
Grown.
CEO Matt Krisiloff put it bluntly on X:
"The potential to redefine fertility is real."
Stay with me. It's beautiful.
The trick wasn't just making an egg.
It was recreating the ovary around it.
Because eggs don't grow alone.
They need their neighborhood.
In mice — yes.
Back in 2016, Japanese scientist Katsuhiko Hayashi grew healthy baby mice from stem-cell-derived eggs.
Those mice grew up. Had babies of their own. Totally normal.
But humans?
Way harder. Way messier. Way slower biology.
A decade later, we finally have the first cracks in the door.
If these cells eventually mature safely, the ripple effects are massive:
This isn't a slightly better IVF.
It's a rewrite of the rules.
Deep breath. Here's the reality check.
The eggs are primary oocytes — very early. Not fertilizable. Not yet.
The findings haven't been peer-reviewed.
Safety testing will take years.
Ethical questions are piling up faster than the science:
Even Krisiloff admits — this is nowhere near a clinic.
Conception has been chasing this since 2018, backed by roughly $20M+ from Silicon Valley believers who thought it was possible when almost nobody else did.
And now?
A blood sample became the first whisper of a human egg.
The biological clock just got a new enemy.
And fertility, as we've known it for 40 years, may be quietly entering its final chapter.
That's all for now!
